Clearside Biomedical, Inc. (NASDAQ:CLSD), currently valued at $81.15 million, is a biotechnology company focused on developing innovative therapies for blinding eye diseases using its proprietary SCS ...

We recently published a list of Why These 15 Software Stocks Are Skyrocketing So Far in 2025. In this article, we are going ...

Zeta Global's Q4 earnings report is expected to be volatile, with significant market movement anticipated. Click here to read ...

We recently published a list of 10 Best Dividend-Paying Beverage Stocks to Buy. In this article, we are going to take a look ...

We recently published a list of 12 Best Robinhood Stocks to Buy Under $20. In this article, we are going to take a look at where NIO Inc.

Q3 results scorecard was modest, driven once again by BFSI, with positive contributions from Technology, Telecom, Healthcare, ...

Borosil Renewables’ shares fell 5% to ₹472 after disappointing Q3FY25 results, showing a net loss of ₹30 crore and a ...

In Q4, significantly more participants increased their retirement contribution rate, led by younger generations – Gen X-ers ...

Leading FMCG companies implement price hikes to combat inflation, focusing on cost-cutting and sourcing efficiencies for ...

Urban Outfitters thrives with Anthropologie & Free People growth, Nuuly's rising subscribers, and strong holiday sales. Learn ...

Indian markets broke their 8-sessions falling streak after recovering from day’s low, thanks to the heavy lifting done by ...